Achieve Life Sciences
ACHV
29 hedge funds and large institutions have $2.81M invested in Achieve Life Sciences in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 8 closing their positions.
15% less funds holding
Funds holding: 34 → 29 (-5)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
30% less capital invested
Capital invested by funds: $4M → $2.81M (-$1.18M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCP
Steamboat Capital Partners
Rye,
New York
|
+$593K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$591K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$63.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$54.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$49.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$57K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$51K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$51K |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$50K |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$39.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
26
Prelude Capital Management
New York
| $3K | +$1.59K | +1 | +50% |
|
27
Group One Trading
Chicago,
Illinois
| $2K | – | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
CLOS
29
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $1K | – | – | – |
|
|
ARTA
30
A.R.T. Advisors
New York
| – | -$57K | -26 | Closed |
|
|
AA
31
Ancora Advisors
Cleveland,
Ohio
| – | -$51K | -23 | Closed |
|
|
PI
32
Putnam Investments
Boston,
Massachusetts
| – | -$50K | -23 | Closed |
|
33
HighTower Advisors
Chicago,
Illinois
| – | -$27K | -12 | Closed |
|
|
VKH
34
Virtu KCG Holdings
New York
| – | -$17K | -8 | Closed |
|
35
Acadian Asset Management
Boston,
Massachusetts
| – | -$13K | -6 | Closed |
|
|
TH
36
Timber Hill
Greenwich,
Connecticut
| – | -$11K | -5 | Closed |
|
|
AIM
37
Acrospire Investment Management
Chicago,
Illinois
| – | -$5K | -2 | Closed |
|
ACHV Hedge Fund Activity: Q3 2016 in Review
29 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2016, worth a combined $2.81M — down 30% from $4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ACHV and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Steamboat Capital Partners, opening a new position worth an estimated $593K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $57K sold.
- 29 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2016, down from 34 in Q2 2016.
- Funds reported $2.81M of Achieve Life Sciences stock for Q3 2016, down 30% quarter-over-quarter.
- 3 funds opened new Achieve Life Sciences positions in Q3 2016 and 8 closed out, a net change of -5 holders.
- The largest Achieve Life Sciences buyer in Q3 2016 was Steamboat Capital Partners, an estimated $593K added.
- The largest Achieve Life Sciences seller in Q3 2016 was A.R.T. Advisors, an estimated $57K sold.
Based on aggregated 13F filings for Q3 2016.